Comparison Chart Vertex Pharmaceuticals Incorporated

VRTX

US92532F1003

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	VERTEX PHARMACEUTICALS INCORPORATED	Other Pharmaceuticals	-0.08%	+0.05%	+7.12%	+4.83%	+140.09%	123B

Market Closed - Nasdaq Other stock markets 04:00:00 2026-07-17 pm EDT			After hours 07:55:20 pm
485.65 ^USD	-0.08%		485.31	-0.07%

Jul. 13	American Academy of Orthopaedic Surgeons Launches New Pain Management Resource Center in Partnership with Curonix LLC Pacira Biosciences, Inc., Vertex Pharmaceuticals, and Viatris	CI
Jul. 13	UBS Adjusts Vertex Pharmaceuticals Price Target to $585 From $545, Maintains Buy Rating	MT

Comparison Chart Vertex Pharmaceuticals Incorporated

Stocks

VRTX

US92532F1003

Pharmaceuticals

Compared values